SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned

被引:0
|
作者
Lytton, Simon D. [1 ]
Ghosh, Asish Kumar [2 ]
机构
[1] SeraDiaLogistics, D-81545 Munich, Germany
[2] Dhaka Med Coll Hosp, Dept Virol, Dhaka 1000, Bangladesh
来源
VIRUSES-BASEL | 2024年 / 16卷 / 07期
关键词
Bangladesh; COVID-19; SARS-CoV-2; variants; vaccination coverage; pandemic preparedness; IMMUNE ESCAPE; CHALLENGES;
D O I
10.3390/v16071077
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The coronavirus infectious disease-2019 (COVID-19) in Bangladesh is a paradigm for how one of the most densely populated countries in the world, with 1270 people per square kilometer, managed to cope with the COVID-19 pandemic under extraordinary circumstances. This review highlights the SARS-CoV-2 variants in Bangladesh and the timeline of their detection in the context of the global experience with the management of vaccination and natural SARS-CoV-2 infection. The motivation to overcome the COVID-19 vaccine dilemma and track Bangladeshi SARS-CoV-2 sub-variants underscores the potential for a low-income country to excel in international medical science, despite having stressed health care services and limited availability of resources for SARS-CoV-2 testing and gene sequencing.
引用
收藏
页数:15
相关论文
共 50 条
  • [2] SARS-CoV-2 (COVID-19) and the lessons learned from global pandemic
    Acquilla, Sushma
    Sibal, Bharat
    Shukla, Heema
    Mathews, Suzanna
    Rai, Gurpreet
    Lakhanpaul, Monica
    INDIAN JOURNAL OF PUBLIC HEALTH, 2021, 65 (03) : 215 - 217
  • [3] Role of COVID-19 Vaccines in SARS-CoV-2 Variants
    Zhou, Zhou
    Zhu, Yimiao
    Chu, Ming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] SARS-CoV-2 variants and ending the COVID-19 pandemic
    Fontanet, Arnaud
    Autran, Brigitte
    Lina, Bruno
    Kieny, Marie Paule
    Karim, Salim S. Abdool
    Sridhar, Devi
    LANCET, 2021, 397 (10278): : 952 - 954
  • [5] SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
    Dao, Thi Loi
    Hoang, Van Thuan
    Colson, Philippe
    Lagier, Jean Christophe
    Million, Matthieu
    Raoult, Didier
    Levasseur, Anthony
    Gautret, Philippe
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [6] Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
    To, Kelvin Kai-Wang
    Sridhar, Siddharth
    Chiu, Kelvin Hei-Yeung
    Hung, Derek Ling-Lung
    Li, Xin
    Hung, Ivan Fan-Ngai
    Tam, Anthony Raymond
    Chung, Tom Wai-Hin
    Chan, Jasper Fuk-Woo
    Zhang, Anna Jian-Xia
    Cheng, Vincent Chi-Chung
    Yuen, Kwok-Yung
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 507 - 535
  • [7] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [8] Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants
    Pagliano, Pasquale
    Spera, Annamaria
    Sellitto, Carmine
    Scarpati, Giuliana
    Folliero, Veronica
    Piazza, Ornella
    Franci, Gianluigi
    Conti, Valeria
    Ascione, Tiziana
    EXPERT OPINION ON DRUG DISCOVERY, 2023, : 1301 - 1311
  • [9] Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants
    Pagliano, Pasquale
    Spera, Annamaria
    Sellitto, Carmine
    Scarpati, Giuliana
    Folliero, Veronica
    Piazza, Ornella
    Franci, Gianluigi
    Conti, Valeria
    Ascione, Tiziana
    EXPERT OPINION ON DRUG DISCOVERY, 2023,
  • [10] Covid-19 convalescent plasma and SARS-CoV-2 viral variants
    Joob, B.
    Wiwanitkit, V.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (03) : 306 - 306